320
Participants
Start Date
July 1, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
contrast-enhanced spectral mammography
"After enrollment, subjects should undergo contrast-enhanced spectral mammography again within within 28 days of MRI examination.~Iopromide/contrast agent is intravenously administered two minutes prior to the first (dual-energy) image acquisition.~* The dosage of iodine contrast agent is calculated as 1.5 mL/kg of iopromide 370 mgI/ml.~* Injecting with high pressure syringe (Stellant, Bayer AG) at an IDR of 3ml/s, followed by 10 ml normal saline."
Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER